gangliotetraose has been researched along with sphingosine in 1 studies
| Studies (gangliotetraose) | Trials (gangliotetraose) | Recent Studies (post-2010) (gangliotetraose) | Studies (sphingosine) | Trials (sphingosine) | Recent Studies (post-2010) (sphingosine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 8,325 | 117 | 3,459 |
| Protein | Taxonomy | gangliotetraose (IC50) | sphingosine (IC50) |
|---|---|---|---|
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 6.3125 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 0.098 | |
| Sphingosine kinase 2 | Homo sapiens (human) | 1.56 | |
| Sphingosine kinase 1 | Homo sapiens (human) | 3.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ledeen, RW; Lu, ZH; Meyenhofer, MF; Wang, J; Wang, Y; Wu, G; Xie, X | 1 |
1 other study(ies) available for gangliotetraose and sphingosine
| Article | Year |
|---|---|
Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
Topics: Animals; Apoptosis; Brain; Disease Susceptibility; G(M1) Ganglioside; Gangliosides; Hippocampus; Kainic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Acetylgalactosaminyltransferases; Neurons; Neuroprotective Agents; Oligosaccharides; Seizures; Sodium-Calcium Exchanger; Sphingosine; Status Epilepticus; Time Factors | 2005 |